drugset / Trial / NCT02910765

Methylene Blue and Ozone in Early Sepsis

NCT02910765

Phase 4 Unknown 40 enrolled Assiut University
RandomizedParallel-groupDouble-blindSupportive care

Summary

effects of methylene blue and ozone O3 therapy effects in early sepsis management , and their implications upon outcome

Timeline

Start
2016-10
Primary completion
2017-03
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylene Blue Diagnostic / imaging agent Intravenous
Comparator Ozone Other / unclassified